IL87755A - Solubility modulated drug delivery device - Google Patents
Solubility modulated drug delivery deviceInfo
- Publication number
- IL87755A IL87755A IL87755A IL8775588A IL87755A IL 87755 A IL87755 A IL 87755A IL 87755 A IL87755 A IL 87755A IL 8775588 A IL8775588 A IL 8775588A IL 87755 A IL87755 A IL 87755A
- Authority
- IL
- Israel
- Prior art keywords
- solubility
- delivery device
- drug delivery
- modulated drug
- modulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10066487A | 1987-09-24 | 1987-09-24 | |
| US11548787A | 1987-11-02 | 1987-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL87755A true IL87755A (en) | 1992-03-29 |
Family
ID=26797415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL87755A IL87755A (en) | 1987-09-24 | 1988-09-15 | Solubility modulated drug delivery device |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0314206B1 (da) |
| JP (1) | JP2915416B2 (da) |
| KR (1) | KR960009409B1 (da) |
| AU (1) | AU608891B2 (da) |
| CA (1) | CA1320886C (da) |
| DE (1) | DE3885232T2 (da) |
| DK (1) | DK528988A (da) |
| ES (1) | ES2059495T3 (da) |
| IE (1) | IE61620B1 (da) |
| IL (1) | IL87755A (da) |
| PT (1) | PT88565B (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
| DE4101873C2 (de) * | 1991-01-23 | 1993-12-09 | Isis Pharma Gmbh | Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände |
| FR2698560B1 (fr) * | 1992-11-30 | 1995-02-03 | Virbac Laboratoires | Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications. |
| GB9609094D0 (en) * | 1996-05-01 | 1996-07-03 | Univ Strathclyde | Delivery device |
| IL118932A0 (en) * | 1996-07-24 | 1996-10-31 | Dexcel Ltd | Controlled release tablets |
| AU721653B2 (en) * | 1996-10-25 | 2000-07-13 | Supernus Pharmaceuticals, Inc. | Soluble form osmotic dose delivery system |
| US6074669A (en) * | 1997-01-20 | 2000-06-13 | Ranbaxy Laboratories Limited | Controlled drug delivery system for diltiazem |
| DE19941769A1 (de) * | 1999-09-02 | 2001-03-08 | Beiersdorf Ag | Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen |
| KR100736132B1 (ko) * | 2000-02-04 | 2007-07-06 | 알자 코포레이션 | 삼투적으로 구동되는 액체 디스펜서 및 코팅 조성물 |
| US6824763B2 (en) | 2002-05-30 | 2004-11-30 | Kimberly-Clark Worldwide, Inc. | Anti-fungal powder having enhanced excipient properties |
| CA2561014C (en) | 2004-04-08 | 2013-09-10 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| AU2005237520B2 (en) | 2004-04-27 | 2012-01-19 | Wyeth | Purification of progesterone receptor modulators |
| EP1773293B1 (en) | 2004-06-17 | 2015-04-15 | Endo Pharmaceuticals Solutions Inc. | Compositions and methods for treating central precocious puberty |
| EP2457564A1 (en) | 2005-03-11 | 2012-05-30 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
| US7759312B2 (en) | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
| JPWO2007037158A1 (ja) * | 2005-09-28 | 2009-04-09 | Ｔｔｉ・エルビュー株式会社 | カプセル型薬物放出装置及びカプセル型薬物放出装置システム |
| US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
| MX2009011641A (es) | 2007-04-27 | 2010-03-04 | Endo Pharmaceuticals Solutions | Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. |
| WO2009158415A1 (en) | 2008-06-25 | 2009-12-30 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
| JP5622725B2 (ja) | 2008-06-25 | 2014-11-12 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． | エキセナチド及び他のポリペプチド類の持続的送達 |
| WO2010015840A1 (en) * | 2008-08-08 | 2010-02-11 | Cipla Limited | Osmotic delivery device with modified release |
| WO2012172449A1 (en) | 2011-06-13 | 2012-12-20 | Pfizer Inc. | Lactams as beta secretase inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
| US4685918A (en) * | 1985-02-01 | 1987-08-11 | Merck & Co., Inc. | Lipid osmotic pump |
| CA1331563C (en) * | 1987-08-03 | 1994-08-23 | Gaylen M. Zentner | Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins |
| NZ226179A (en) * | 1987-09-24 | 1991-04-26 | Merck & Co Inc | Controlled porosity osmotic pump for sustained release of pharmaceutical agents |
-
1988
- 1988-09-13 AU AU22129/88A patent/AU608891B2/en not_active Ceased
- 1988-09-15 IL IL87755A patent/IL87755A/xx not_active IP Right Cessation
- 1988-09-16 ES ES88202033T patent/ES2059495T3/es not_active Expired - Lifetime
- 1988-09-16 DE DE88202033T patent/DE3885232T2/de not_active Expired - Fee Related
- 1988-09-16 EP EP88202033A patent/EP0314206B1/en not_active Expired - Lifetime
- 1988-09-21 CA CA000578060A patent/CA1320886C/en not_active Expired - Fee Related
- 1988-09-21 PT PT88565A patent/PT88565B/pt not_active IP Right Cessation
- 1988-09-22 JP JP63236647A patent/JP2915416B2/ja not_active Expired - Fee Related
- 1988-09-23 KR KR1019880012294A patent/KR960009409B1/ko not_active IP Right Cessation
- 1988-09-23 DK DK528988A patent/DK528988A/da not_active Application Discontinuation
- 1988-09-23 IE IE289888A patent/IE61620B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3885232D1 (de) | 1993-12-02 |
| IE61620B1 (en) | 1994-11-16 |
| ES2059495T3 (es) | 1994-11-16 |
| KR890004679A (ko) | 1989-05-09 |
| EP0314206A1 (en) | 1989-05-03 |
| CA1320886C (en) | 1993-08-03 |
| KR960009409B1 (ko) | 1996-07-19 |
| DK528988A (da) | 1989-05-18 |
| JP2915416B2 (ja) | 1999-07-05 |
| AU2212988A (en) | 1989-04-06 |
| IE882898L (en) | 1989-03-24 |
| JPH0291017A (ja) | 1990-03-30 |
| DE3885232T2 (de) | 1994-04-07 |
| DK528988D0 (da) | 1988-09-23 |
| AU608891B2 (en) | 1991-04-18 |
| PT88565A (pt) | 1988-10-01 |
| PT88565B (pt) | 1993-03-31 |
| EP0314206B1 (en) | 1993-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL87755A (en) | Solubility modulated drug delivery device | |
| GB8712975D0 (en) | Drug delivery device | |
| GB8712176D0 (en) | Drug delivery system | |
| GB8609218D0 (en) | Drug delivery device | |
| GB2185397B (en) | Drug delivery system | |
| GB2185187B (en) | Transdermal drug delivery device | |
| ZA87737B (en) | Drug delivery system | |
| ZA873091B (en) | Pulsed drug delivery | |
| AU7717287A (en) | Drug infusion device | |
| GB8710094D0 (en) | Pulsed drug delivery | |
| IL86076A (en) | Transdermal drug delivery device | |
| IL86802A0 (en) | Drug delivery devices | |
| PT80525A (en) | Sustained release drug delivery device | |
| GB9016056D0 (en) | Transdermal medicine delivery devices | |
| ZA887009B (en) | A solubility modulated drug delivery device | |
| IL82675A (en) | Drug delivery apparatus | |
| GB8715911D0 (en) | Drug delivery device | |
| GB8620226D0 (en) | Drug delivery device | |
| GB8706780D0 (en) | Drug delivery device | |
| GB8622697D0 (en) | Drug delivery device | |
| GB8613382D0 (en) | Drug delivery device | |
| EP0412158A4 (en) | Oncostatic drug | |
| AU3034589A (en) | Intraruminal drug delivery device | |
| IL82753A0 (en) | Transdermal drug delivery device | |
| IL83469A0 (en) | Transdermal drug delivery device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |